NEPHROSCAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nephroscan, and what generic alternatives are available?
Nephroscan is a drug marketed by Theragnostics and is included in one NDA.
The generic ingredient in NEPHROSCAN is technetium tc-99m succimer. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m succimer profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEPHROSCAN?
- What are the global sales for NEPHROSCAN?
- What is Average Wholesale Price for NEPHROSCAN?
Summary for NEPHROSCAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in NEPHROSCAN? | NEPHROSCAN excipients list |
| DailyMed Link: | NEPHROSCAN at DailyMed |
Pharmacology for NEPHROSCAN
| Drug Class | Lead Chelator |
| Mechanism of Action | Lead Chelating Activity |
US Patents and Regulatory Information for NEPHROSCAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theragnostics | NEPHROSCAN | technetium tc-99m succimer | POWDER;INTRAVENOUS | 214993-001 | Feb 18, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
